The potential role of tubeimosides in cancer prevention and treatment

Bandhavkar, 2016, Cancer stem cells: a metastasizing menace, Cancer Med, 5, 649, 10.1002/cam4.629 Millimouno, 2014, Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature, Cancer Prev. Res., 7, 1081, 10.1158/1940-6207.CAPR-14-0136 Mahmoud, 2017, Deoxyelephantopin and isodeoxyelephantopin as potential anticancer agents with effects on multiple signaling pathways, Molecules, 22, 1013, 10.3390/molecules22061013 Liang, 2010, Circumventing tumor resistance to chemotherapy by nanotechnology, Methods Mol. Biol., 595, 467, 10.1007/978-1-60761-416-6_21 Crespo-Ortiz, 2012, Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug, J. Biomed. Biotechnol., 2012, 247597 Chan, 2015, Elephantopus scaber induces apoptosis through ROS-dependent mitochondrial signaling pathway in HCT116 human colorectal carcinoma cells, J. Ethnopharmacol., 168, 291, 10.1016/j.jep.2015.03.072 Lau, 2015, Potent PPARγ ligands from Swietenia macrophylla are capable of stimulating glucose uptake in muscle cells, Molecules, 20, 22301, 10.3390/molecules201219847 Supriady, 2015, SMEAF attenuates the production of pro-inflammatory mediators through the inactivation of Akt-dependent NF-κB, p38 and ERK1/2 pathways in LPS-stimulated BV-2 microglial cells, J. Funct. Food, 17, 434, 10.1016/j.jff.2015.05.042 Liweber, 2013, Targeting apoptosis pathways in cancer by Chinese medicine, Cancer Lett., 332, 304, 10.1016/j.canlet.2010.07.015 Xia, 2014, Anti-tumor effects of traditional Chinese medicine give a promising perspective, J. Canc. Res. Therapeut., 10, S1, 10.4103/0973-1482.139741 Nie, 2016, Efficacy of traditional Chinese medicine in treating cancer, Biomed. Rep., 4, 3, 10.3892/br.2015.537 Tan, 2011, Anti-cancer natural products isolated from Chinese medicinal herbs, Chin. Med., 6, 27, 10.1186/1749-8546-6-27 Parekh, 2009, A new dawn for the use of traditional Chinese medicine in cancer therapy, Mol. Canc., 8, 21, 10.1186/1476-4598-8-21 Ye, 2015, Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis, Oncol. Lett., 10, 1240, 10.3892/ol.2015.3459 Carmady, 2011, Use of Chinese medicine by cancer patients: a review of surveys, Chin. Med., 6, 22, 10.1186/1749-8546-6-22 Tang, 2005, Isolation and structural elucidation of bioactive cyclic bisdesmosides from tubers of Bolbostemma paniculatum, Pharmaceut. Care Res., 5, 216 Jia, 2015, Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway, OncoTargets Ther., 8, 303 Gu, 2016, Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model, Oncotarget, 7 Peng, 2016, Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression, BMB Rep, 49, 502, 10.5483/BMBRep.2016.49.9.030 Bian, 2015, Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway, Int. J. Clin. Exp. Pathol., 8, 12517 Yang, 2016, Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro, Acta Pharmacol. Sin., 37, 950, 10.1038/aps.2016.34 Cui, 2016, Determination of tubeimoside I content in Bolbostemma paniculatum (Maxim.) Franquet and its anti-proliferative effect on human erythroleukemia K562 cells, Biomed. Res., 27, 1171 Cheng, 2006, Tubeimoside V, a new cyclic bisdesmoside from tubers of Bolbostemma paniculatum, functions by inducing apoptosis in human glioblastoma U87MG cells, Bioorg. Med. Chem. Lett, 16, 4575, 10.1016/j.bmcl.2006.06.020 Wu, 2018, The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro, OncoTargets Ther., 11, 3989, 10.2147/OTT.S164503 Wang, 2018, Tubeimoside V sensitizes human triple negative breast cancer MDA-MB-231 cells to anoikis via regulating caveolin-1-related signaling pathways, Arch. Biochem. Biophys., 646, 10, 10.1016/j.abb.2018.03.029 State Administration of Traditional Chinese Medicine, 1999, 5, 502 Committee of Pharmacopeia, 2010, 1, 155 Zhao, 1983, 123 Wang, 1981, Studies on antitumor action of extracts of Bolbostemma paniculatum (Maxim.) Franquet, J. Shaanxi Med. J., 10, 55 Zhang, 2014, Analysis of allergens in tubeimu saponin extracts by using rat basophilic leukemia 2H3 cell-based affinity chromatography coupled to liquid chromatography and mass spectrometry, J. Separ. Sci., 37, 3384, 10.1002/jssc.201400280 Tang, 2015, Bioassay-guided isolation and identification of cytotoxic compounds from Bolbostemma paniculatum, J. Ethnopharmacol., 169, 18, 10.1016/j.jep.2015.04.003 Kong, 1986, Structural study of tubeimoside i, a constituent of tu-bei-mu, Tetrahedron Lett., 27, 5765, 10.1016/S0040-4039(00)85321-6 Kasai, 1986, Tubeimoside I, a new cyclic bisdesmoside from Chinese cucurbitaceous folk medicine “tubeimu”, a tuber of Bolbostemma paniculatum, Chem. Pharm. Bull., 34, 3974, 10.1248/cpb.34.3974 Liu, 2004, New triterpenoid saponins from bulbs of Bolbostemma paniculatum, Planta Med., 70, 458, 10.1055/s-2004-818976 Xu, 2009, Tubeimoside-1 exerts cytotoxicity in HeLa cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways, J. Proteome Res., 8, 1585, 10.1021/pr801001j Yu, 1994, Potent anti-tumor activity and low toxicity of tubeimoside 1 isolated from Bolbostemma paniculatum, Planta Med., 60, 204, 10.1055/s-2006-959459 Yu, 1996, Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by Tubeimoside 1, Planta Med., 62, 119, 10.1055/s-2006-957831 Wang, 2011, Natural plant extract tubeimoside I induces cytotoxicity via the mitochondrial pathway in human normal liver cells, Mol. Med. Rep., 4, 713 Ma, 2008, Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin, Cancer Chemother. Pharmacol., 62, 559, 10.1007/s00280-007-0635-0 Ma, 1994, Study on anti-tumor activity of Tubeimoside saponin A, Chin. J. Oncol., 21, 446 Yu, 2001, Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects, Acta Pharmacol. Sin., 22, 463 Chao, 2012, Effects of tubeimoside-2 on proliferation and cell cycle of human hepatocellular carcinoma cell line HepG2, Jiangsu Med. J., 38, 1740 Chao, 2006, Mechanisms of apoptosis induced by tubeimosides in human rectal cancer cell line SW480 in vitro, Chin. Pharmacol. Bull., 22, 880 Chao, 2007, Extraction of tubeimosides from Bolbostemma paniculatum and their effects on human erythroleukamia K562, J. Southeast Univ. (Nat. Sci. Ed.), 29, 89 Liang, 2007, Quantitative determination of the anticancer agent tubeimoside I in rat plasma by liquid chromatography coupled with mass spectrometry, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 845, 84, 10.1016/j.jchromb.2006.07.053 Li, 2018, A hybrid method for the determination of tubeimoside I in rat plasma after oral administration by LC-IT-TOF and UPLC-MS/MS, Biomed. Chromatogr., 13 Chen, 2018, Pharmacokinetics and bioavailability study of tubeimoside I in ICR mice by UPLC-MS/MS, J. Anal. Methods Chem., 2018 Chen, 2014, The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review, Med. Res. Rev., 34, 768, 10.1002/med.21304 Lin, 2016, TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53/MDM2-dependent mechanism, a quantitative proteomics study, Biochim. Biophys. Acta, 1864, 204, 10.1016/j.bbapap.2015.11.001 Hao, 2015, Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway, Int. J. Clin. Exp. Pathol., 8, 12075 Zhang, 2011, Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells, Mol. Med. Rep., 4, 25 Yu, 2008, Effects of tubeimoside 1 on adhesion, invasion and migration of a human highly metastatic giant lung carcinoma cell line PGCL3, Chin. J. Nat. Med., 6, 135, 10.3724/SP.J.1009.2008.00135 Wang, 2016, Effect of Tubeimoside on proliferation and morphological of androgen-independent prostate cancer PC3 cells, Modern Oncol, 24, 2509 Xu, 2011, Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells, J. Proteomics, 75, 491, 10.1016/j.jprot.2011.08.014 Wang, 2006, Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line, Cancer Chemother. Pharmacol., 57, 389, 10.1007/s00280-005-0047-y Ma, 2004, Induction of cell cycle arrest and apoptosis by tubeimoside I isolated from Bolbostemma Paniculatum in HeLa cells, Chin. J. Clin. Pharm. Therapeut., 9, 261 Yang, 2002, Cell cycle arrest and apoptosis induced by tubeimoside in HeLa cell, Ai Zheng, 21, 346 Lin, 2014, Research on the interaction between tubeimoside 1 and HepG2 cells using the microscopic imaging and fluorescent spectra method, Comput. Math. Methods. Med., 2014, 10.1155/2014/470452 Yin, 2011, NF-κB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G2/M cell cycle arrest, Food Chem. Toxicol., 49, 3046, 10.1016/j.fct.2011.10.001 Wang, 2011, Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells, Biol. Pharm. Bull., 34, 831, 10.1248/bpb.34.831 Liu, 2006, Apoptosis of human erthroleukemia cell line K562 induced by Tubeimoside I, J. Hangzhou. Teach. Coll., 5, 126 Liu, 2006, Differentiation-inducing activity of tubeimoside I in human erythroleukemia K562 cells, Chin. J. Clin. Pharm. Therapeut., 11, 43 Hu, 2003, Effects of Tubeimoside I on cell cycle and apoptosis of human myeloblastic leukemia cells HL-60, Chin. J. Clin. Oncol., 30, 163 Chen, 2012, Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca2+ and caspase-dependent signaling pathways, Int. J. Oncol., 40, 535 Liu, 2011, Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways, Mol. Med. Rep., 4 Zhang, 2013, Effects of tubeimoside-1 on the proliferation and apoptosis of BGC823 gastric cancer cells in vitro, Oncol. Lett., 5, 801, 10.3892/ol.2013.1117 Rasul, 2012, Tubeimoside-1 inhibits growth via the induction of cell cycle arrest and apoptosis in human melanoma A375 cells, Bangladesh J. Pharmacol., 7, 150, 10.3329/bjp.v7i3.11507 Rasul, 2014, Tubeimoside-1 upregulates p21 expression and induces apoptosis and G2/M phase cell cycle arrest in human bladder cancer T24 cells, Bangladesh J. Pharmacol., 9, 595, 10.3329/bjp.v9i4.19989 Xu, 2013, Intrinsic apoptotic pathway and G2/M cell cycle arrest involved in tubeimoside I-induced EC109 cell death, Chin. J. Canc. Res., 25, 312 Huang, 2011, Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway, Int. J. Mol. Med., 28, 579 Weng, 2003, Apoptosis of human nasopharyngeal carcinoma CNE-2Z cells induced by tubeimoside I, Ai Zheng, 22, 806 Yu, 2008, Effects of tubeimoside 1 on apoptosis of human umbilical vein endothelial cells and inhibition of tumor-induced angiogenesis, Chin. J. Cell. Biol., 30, 747 Fuchs, 2011, Programmed cell death in animal development and disease, Cell, 147, 742, 10.1016/j.cell.2011.10.033 Wu, 2014, Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis, Int. J. Biol. Sci., 10, 1072, 10.7150/ijbs.9719 Cotter, 2009, Apoptosis and cancer: the genesis of a research field, Nat. Rev. Canc., 9, 501, 10.1038/nrc2663 Fulda, 2015, Targeting apoptosis for anticancer therapy, Semin. Canc. Biol., 31, 84, 10.1016/j.semcancer.2014.05.002 Hassan, 2014, Apoptosis and molecular targeting therapy in cancer, BioMed Res. Int., 2014, 150845, 10.1155/2014/150845 Dall'Acqua, 2014, Natural products as antimitotic agents, Curr. Top. Med. Chem., 14, 2272, 10.2174/1568026614666141130095311 Kischkel, 1995, Cytotoxicity-dependent Apo-1 (Fas/Cd95)-associated proteins form a death-inducing signaling complex (Disc) with the receptor, EMBO J., 14, 5579, 10.1002/j.1460-2075.1995.tb00245.x Bake, 2014, Synergistic interaction of Smac mimetic and IFN alpha to trigger apoptosis in acute myeloid leukemia cells, Cancer Lett., 355, 224, 10.1016/j.canlet.2014.08.040 Igney, 2002, Death and anti-death: tumor resistance to apoptosis, Nat. Rev. Canc., 2, 277, 10.1038/nrc776 Khan, 2016, Killing cancer with platycodin D through multiple mechanisms, J. Cell Mol. Med., 20, 389, 10.1111/jcmm.12749 Vela, 2015, Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside, Curr. Opin. Pharmacol., 23, 74, 10.1016/j.coph.2015.05.014 Fesik, 2005, Promoting apoptosis as a strategy for cancer drug discovery, Nat. Rev. Canc., 5, 876, 10.1038/nrc1736 Schuler, 2001, Mechanisms of p53-dependent apoptosis, Biochem. Soc. Trans., 29, 684, 10.1042/bst0290684 Hu, 2012, Real-time imaging of apoptosis induction of human breast cancer cells by the traditional Chinese medicinal herb tubeimu, Anticancer Res., 32, 2509 Yokouchi, 2007, A typical, bidirectional regulation of cadmium-induced apoptosis via distinct signaling of unfolded protein response, Cell Death Differ., 14, 1467, 10.1038/sj.cdd.4402154 Boyce, 2006, Cellular response to endoplasmic reticulum stress: a matter of life or death, Cell Death Differ., 13, 363, 10.1038/sj.cdd.4401817 James, 2014, Nucleolar stress with and without p53, Nucleus, 5, 402, 10.4161/nucl.32235 Görlach, 2015, Reactive oxygen species, nutrition, hypoxia and diseases: problems solved?, Redox Biol, 6, 372, 10.1016/j.redox.2015.08.016 Görlach, 2015, Calcium and ROS: a mutual interplay, Redox Biol, 6, 260, 10.1016/j.redox.2015.08.010 Redza-Dutordoir, 2016, Activation of apoptosis signaling pathways by reactive oxygen species, Biochim. Biophys. Acta, 1863, 2977, 10.1016/j.bbamcr.2016.09.012 Benada, 2015, Targeting the checkpoint to kill cancer cells, Biomolecules, 5, 1912, 10.3390/biom5031912 Gire, 2015, Senescence from G2 arrest, revisited, Cell Cycle, 14, 297, 10.1080/15384101.2014.1000134 Dutto, 2015, Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology, Arch. Toxicol., 89, 155, 10.1007/s00204-014-1430-4 Yang, 2010, Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2, Clin. Canc. Res., 16, 3171, 10.1158/1078-0432.CCR-09-3171 Li, 1998, Research on the inhibitory effect of cell cycle in human renal cell carcinoma induced by tubeimoside, Chin. J. Surg. Integr. Trad. West. Med., 4, 100 Chen, 2017, Approaches for studying autophagy in Caenorhabditis elegans, Cells, 6, E27, 10.3390/cells6030027 Li, 2015, Functions of autophagy in pathological cardiac hypertrophy, Int. J. Biol. Sci., 11, 672, 10.7150/ijbs.11883 Panda, 2015, Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics, Semin. Cell Dev. Biol., 39, 43, 10.1016/j.semcdb.2015.02.013 Law, 2014, Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells, Sci. Rep., 4, 5510, 10.1038/srep05510 Lee, 2013, The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma, PloS One, 8, 10.1371/annotation/154eb7f6-687c-4416-afc6-006658035c57 Wu, 2015, Heteronemin, a spongean sesterterpene, induces cell apoptosis and autophagy in human renal carcinoma cells, BioMed Res. Int., 2015, 738241 Jiang, 2018, Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway, Acta Pharmacol. Sin., 12, 1 Gong, 2018, Tubeimoside 1 acts as a chemotherapeutic synergist via stimulating macropinocytosis, Front. Pharmacol., 9, 1044, 10.3389/fphar.2018.01044 Bonapace, 2014, Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis, Nature, 515, 130, 10.1038/nature13862 Tassi, 2006, Tumor angiogenesis: initiation and targeting-therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas, Cancer Res. Treat., 38, 189, 10.4143/crt.2006.38.4.189 Hu, 2003, Inhibition of angiogenesis by tubeimoside I isolated from Bolstemma paniculatun, Chin. Pharm. Bull., 19, 715 Kumar, 2009, Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds, Br. J. Surg., 96, 1484, 10.1002/bjs.6778 Guo, 2008, Experimental study on the effect on the expression of VEGF and FGF2 after embolization by tubeimoside microcapsule, J. Pract. Radiol., 24, 1272 Kang, 2015, B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway, Cancer Cell Int., 15, 45, 10.1186/s12935-015-0195-z Harlozinska, 2005, Progress in molecular mechanisms of tumor metastasis and angiogenesis, Anticancer Res., 25, 3327 Xu, 2015, CXCR4 in breast cancer: oncogenic role and therapeutic targeting, Drug Des. Dev. Ther., 9, 4953 He, 2004, Advances in biomechanics research of cancer cells, Foreign Med. Sci. Stomotol., 31, 273 Zhao, 2013, In vitro assay of cytoskeleton nanomechanics as a tool for screening potential anticancer effects of natural plant extract, tubeimoside I on human hepatoma (HepG2) cells, Chin. Sci. Bull., 58, 2576, 10.1007/s11434-013-5757-7 Wang, 2006, Effects of tubeimoside on adhesion, invasion and migration of a human highly metastatic giant lung carcinoma cell line PGCL3, Chin. J. Clin. Pharm. Therapeut., 11, 39 Wang, 2006, Inhibitory effects of tubeimoside 1, a cyclic bisdesmoside isolated from Bolbostemma paniculatum, on metastases of mouse B16 melanoma and Lewis lung carcinoma, Chin. J. Clin. Pharmacol. Therapeut., 11, 764 Shi, 2018, Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway, Mol. Med. Rep., 17, 4327 Wang, 2018, Inhibition of growth and metastasis of triple-negative breast cancer targeted by traditional Chinese medicine Tubeimu in orthotopic mice models, Chin. J. Canc. Res., 30, 112, 10.21147/j.issn.1000-9604.2018.01.12 Simpson, 2008, Anoikis resistance and tumor metastasis, Cancer Lett., 272, 177, 10.1016/j.canlet.2008.05.029 D'Amato, 2015, A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer, Cancer Res., 75, 4651, 10.1158/0008-5472.CAN-15-2011 Shatz, 2008, Caveolin-1: a tumor-promoting role in human cancer, Int. J. Radiat. Biol., 84, 177, 10.1080/09553000701745293 Fitzpatrick, 2013, Metabolomics--a novel window into inflammatory disease, Swiss Med. Wkly., 143, w13743 Shacter, 2002, Chronic inflammation and cancer, Oncology, 16, 217 Yu, 1992, Potent anti-tumorigenic effect of tubeimoside 1 isolated from the bulb of Bolbostemma paniculatum (Maxim) Franquet, Int. J. Canc., 50, 635, 10.1002/ijc.2910500425 Yu, 1995, Inhibition of the tumor promoting action of 12-O-tetradecanoyl-phorbol-13-acetate by tubeimoside III isolated from Bolbostemma paniculatum, Carcinogenesis, 16, 3045, 10.1093/carcin/16.12.3045 Yoon, 2005, Molecular targets of dietary polyphenols with anti-inflammatory properties, Yonsei Med. J., 46, 585, 10.3349/ymj.2005.46.5.585 Wu, 2013, Tubeimoside-1 attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models, Immunopharmacol. Immunotoxicol., 35, 514, 10.3109/08923973.2013.810643 He, 2018, Tubeimoside I protects dopaminergic neurons against inflammation-mediated damage in lipopolysaccharide (LPS)-evoked model of Parkinson's disease in rats, Int. J. Mol. Sci., 19, 2242, 10.3390/ijms19082242 Zhang, 2018, Tubeimoside I attenuates inflammation and oxidative damage in a mice model of PM2.5-induced pulmonary injury, Exp. Ther. Med., 15, 1602 Liu, 2018, Inhibitory effects of tubeimoside I on synoviocytes and collagen-induced arthritis in rats, J. Cell. Physiol., 233, 8740, 10.1002/jcp.26754 Huang, 2015, Tubeimoside-1 inhibits the proliferation and activation of mouse T lymphocytes through signal transduction pathways, Immunopharmacol. Immunotoxicol., 37, 366, 10.3109/08923973.2015.1063644 Chen, 2014, Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies, Cancer Lett., 354, 5, 10.1016/j.canlet.2014.08.003 Liu, 2011, Tubeimoside 1 enhances chemosensitivity of drug-resistant ovarian cancer A2780 & DDP cells to cisplatin, J. Thi. Mil. Med. Univ., 33, 695 Zhang, 2010, Experimental study of cisplatin and tubeimoside on proliferation and inhibitory effects of human cervical cancer cells, Mod. Oncol., 18, 1909 Chen, 2016, Synergetic effects of aqueous extracts of fuzi (radix Aconiti Lateralis Preparata) and tubeimu (rhizoma Bolbostemmatis) on MDA-MB-231 and SKBR3 cells, J. Tradit. Chin. Med., 36, 113, 10.1016/S0254-6272(16)30017-6